论文部分内容阅读
目的:探究盐酸氨溴索联合莫西沙星治疗肺炎的疗效及安全性。方法:选取2015年3月至2016年12月我院接诊的肺炎患者106例为研究对象,按照随机数表法分为两组,各53例。两组均实施常规对症治疗,对照组采用盐酸莫西沙星注射液治疗,观察组在对照组基础上联合注射用盐酸氨溴索治疗。比较两组治疗效果及用药安全性。结果:对照组患者治疗总有效率比观察组低,差异有统计学意义(P<0.05);对照组患者不良反应发生率比观察组高,差异有统计学意义(P<0.05)。结论:盐酸氨溴索联合莫西沙星治疗肺炎能够有效改善患者临床症状,提高治疗效果,且用药具有一定的安全性。
Objective: To investigate the efficacy and safety of ambroxol hydrochloride and moxifloxacin in the treatment of pneumonia. Methods: From March 2015 to December 2016, 106 cases of pneumonia patients admitted to our hospital were selected as the research object. According to the random number table, the patients were divided into two groups of 53 cases. Both groups were given conventional symptomatic treatment, the control group with moxifloxacin hydrochloride injection, the observation group in the control group on the basis of combination with ambroxol hydrochloride treatment. The therapeutic effect and medication safety were compared between the two groups. Results: The total effective rate in the control group was lower than that in the observation group (P <0.05). The incidence of adverse reactions in the control group was higher than that in the observation group (P <0.05). Conclusion: Ambroxol hydrochloride combined with moxifloxacin in the treatment of pneumonia can effectively improve the clinical symptoms and improve the therapeutic effect, and the medication has some safety.